M&A news

The Carlyle Group Completes Surventis Acquisition for

Surventis acquired by The Carlyle Group

AcquisitionUSD8,942,830,909Manufacturing

Get the full Surventis company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Surventis logo
Acquired

Surventis

Manufacturing

Deal value

USD8,942,830,909

July 4, 2026

The Carlyle Group logo
Acquirer

The Carlyle Group

Financial Services

The Carlyle Group has acquired Surventis, a global leader in coatings and surface treatment solutions, for $8.9 billion. Surventis, formerly BASF Coatings, is headquartered in Muenster, Germany, and boasts over 130 years of expertise in delivering high-performance surfaces. The company serves more than 42,000 customers in over 140 countries, employing approximately 10,700 people. Its operations span Mobility Coatings, Refinish Coatings, and Surface Treatment, with a strong portfolio of brands including Chemetall®, Glasurit®, and R-M®.

This acquisition represents a significant strategic investment for The Carlyle Group, reinforcing its commitment to high-growth industrial sectors. Surventis's established market leadership, driven by its passion for science and innovation, provides a compelling platform for long-term value creation. The company's comprehensive offerings across diverse applications, from automotive refinish to specialized surface treatment, align with The Carlyle Group's strategy to invest in companies with strong fundamentals and significant growth potential in essential global markets.

The integration is expected to foster substantial synergies by combining Surventis's deep technical knowledge, trusted customer relationships, and extensive global footprint with The Carlyle Group's strategic guidance and capital resources. This partnership aims to accelerate Surventis's innovation pipeline and expand its reach into new markets, enhancing its ability to deliver lasting value to customers. The combined entity is positioned to strengthen its leadership in the global coatings and surface treatment industry, driving sustained growth and advancing specialized solutions worldwide.

No buying signals identified yet.

Unlock GTM signals

Discover Surventis's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Surventis.

Unlock decision-makers